JPRN-UMIN000015694
Completed
Phase 1
Safety and efficacy of haploidentical hematopoietic stem-cell transplantation followed by post-transplant high-dose cyclophosphamide (RIC) - Tsukuba-Haplo RIC
niversity of Tsukuba, Department of Hematology0 sites10 target enrollmentJanuary 1, 2015
Conditionshematological malignancy
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- hematological malignancy
- Sponsor
- niversity of Tsukuba, Department of Hematology
- Enrollment
- 10
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients with anti\-HLA antibody 2\) Patients with uncontrollable psychological complications 3\) Patients with active double cancer 4\) Patients with uncontrollable active infection 5\) Pregnant women 6\) Patients who are judged inappropriate by investigators
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Safety and efficacy of haploidentical hematopoietic stem-cell transplantation followed by post-transplant high-dose cyclophosphamidehematological malignancyJPRN-UMIN000006631niversity of Tsukuba, Department of Hematology25
Unknown
Phase 4
Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia MajorThalassemia MajorNCT03171831First Affiliated Hospital of Guangxi Medical University30
Completed
Not Applicable
Safety and efficacy of allogeneic hematopoietic stem cell transplantation for refractory hematological malignancies with plerixafor-combined myeloablative conditioningacute leukemia, myelodysplastic syndrome, chronic myelogenous leukemiaJPRN-UMIN000009485Division of Hematology Keio University School of Medicine12
Not yet recruiting
Not Applicable
Efficacy and safety of allogeneic hematopoietic cell transplantation using post-transplantation cyclophosphamide for graft-versus-host disease prophylaxis in higher-risk myelodysplastic syndrome, chronic myelomonocytic leukemia, and secondary AML patientsKCT0004151Asan Medical Center113
Completed
Phase 1
Haploidentical hematopoietic stem cell transplantation in combination with posttransplant cyclophosphamide and ATG-thymoglobulin Phase I studyhematological malignancyJPRN-UMIN000009374ational Cancer Center Hospital15